On Tuesday, Sept. 25, 2018, Mayor Rahm Emanuel formally proclaimed November 8th to be Chicago Alzheimer’s Awareness Day.
Yesterday, I proudly attended and participated in an event hosted by Great Lakes Clinical Trials to raise awareness about the Alzheimer’s disease and honor those who have joined the fight as participants in clinical research programs to continue to find a way to combat the disease.
This city-wide event was a great opportunity for our community to engage and encourage one another to learn more about how the Alzheimer’s disease can affect our loved ones, and even ourselves, so we can begin to be proactive in securing the proper education about early onset signs, prevention, treatment, and care management.
This event was also an opportunity to come together to honor those individuals who have already joined the awareness efforts by participating in the ongoing clinical research programs and events such as these to make sure the community is aware of the valuable resources organizations like Great Lakes Clinical Trials and the Global Alzheimer’s Platform Foundation can offer.
One of the reasons events like these are so vital to our community is because they are part of a nationwide effort to increase and streamline recruitment efforts for Alzheimer’s clinical trials and studies. The more involvement these programs can drive, the more streamlined the process can become resulting in faster trials, faster treatments and hopefully faster results. We need these types of programs and clinical trials to help us find answers.
If you were unable to attend the event but would like to learn more about Alzheimer’s disease or the Great Lakes Clinical Trials, please visit their website. Great Lakes Clinical Trials is currently offering no-cost, no-obligation Memory Assessments and Consultation visits to adults over the age of 50, so please reach out to learn more about scheduling an appointment.
The Great Lakes Clinical Trials staff was very helpful in assisting me with signing up and administering my free genetic testing for the Alzheimer’s gene.